15 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Non-Sterile Ultrasound Transmission Gels

FDA 510(k)
FDA Class 2 ·Radiology

NONINVASIVE BLOOD PRESSURE MONITOR, MODELS MD-880B AND MD-900T

FDA 510(k)
FDA Class 2 ·Cardiovascular

PLUM 360 INFUSION SYSTEM WITH HOSPIRA MEDNET, SMART CARD PLUG N PLAY CE 3.0 MODULE FOR PLUM A+ INFUSION SYSTEM UPGRADE

FDA 510(k)
FDA Class 2 ·General Hospital

CONTOUR® PLUS BLUE

FDA Adverse Event
Malfunction ·ASCENSIA DIABETES CARE US INC.·Product code NBW·May 12, 2026

ACCU-CHEK ULTRAFLEX INFUSION SET

FDA Adverse Event
Injury ·DISETRONIC MEDICAL SYSTEMS·Product code FPA·November 20, 2008

SILIC FOLEY CATH 5/10 ML/5

FDA Adverse Event
Injury ·COLOPLAST A/S·Product code EZL·September 9, 2011

MECHANICAL (MANUAL) WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code IOR·July 22, 2013

CONTOUR® CARE

FDA Adverse Event
Malfunction ·ASCENSIA DIABETES CARE US INC.·Product code NBW·December 3, 2025

CONTOUR® CARE

FDA Adverse Event
Malfunction ·ASCENSIA DIABETES CARE US INC.·Product code NBW·April 23, 2026

UNSPECIFIED PRIMARY PLUM SET

FDA Adverse Event
Malfunction ·ICU MEDICAL COSTA RICA LTD.·Product code FPA·October 3, 2024

UNSPECIFIED PRIMARY PLUM SET CLAVE PORT, CLAVE Y-SITE, SECURE LOCK

FDA Adverse Event
Malfunction ·ICU MEDICAL COSTA RICA LTD.·Product code FPA·November 24, 2024

CONTOUR® NEXT

FDA Adverse Event
Injury ·ASCENSIA DIABETES CARE US INC.·Product code NBW·April 8, 2025

CONTOUR® PLUS ELITE

FDA Adverse Event
Malfunction ·ASCENSIA DIABETES CARE US INC.·Product code NBW·May 8, 2025

Model Number L111, ESSENTIO DR SL MRI Pacemaker

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·October 22, 2025

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014